BMYBristol-Myers Squibb Co.

CSNew York Stock Exchange (XNYS)·USD

Identity

Security key: 12697
Ticker: BMY
Type: CS — Common Stock
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 1952-06-23
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: BMY

Detail

Enriched 2026-08-14 20:47

Market cap: $130,120,923,587.2
Shares outstanding (class): 2,042,714,656
Shares outstanding (weighted): 2,042,714,656
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 32,500
Location: PRINCETON, NJ
Homepage: https://www.bms.com
Description: Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Market cap and share counts drift.

Funds holding this security

583 funds · 615 positions · $23.40B reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$3.92B	0.20%	64,679,742 NS	FIGI
VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS	VOO	$3.14B	0.22%	51,751,757 NS	FIGI
iShares Core S&P 500 ETF iShares Trust	IVV	$1.59B	0.22%	26,190,904 NS	FIGI
N/A —	—	$1.44B	0.22%	23,744,103 NS	FIGI
VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS	VTV	$1.14B	0.51%	18,835,882 NS	FIGI
State Street(R) Health Care Select Sector SPDR(… SELECT SECTOR SPDR TRUST	XLV	$898.81M	2.33%	14,819,702 NS	FIGI
VANGUARD PRIMECAP FUND VANGUARD CHESTER FUNDS	—	$866.90M	1.20%	14,293,460 NS	FIGI
VANGUARD INSTITUTIONAL INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS	—	$696.42M	0.22%	11,482,539 NS	FIGI
JPMorgan Large Cap Growth Fund JPMorgan Trust II	—	$530.66M	0.49%	8,749,509 NS	FIGI
JPMorgan Equity Premium Income ETF J.P. Morgan Exchange-Traded Fund Trust	JEPI	$503.68M	1.15%	8,304,755 NS	FIGI
JPMorgan Equity Income Fund JPMorgan Trust II	—	$375.43M	0.91%	6,190,077 NS	FIGI
VanEck Morningstar Wide Moat ETF VanEck ETF Trust	MOAT	$337.21M	2.90%	5,559,989 NS	FIGI
VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS	—	$277.75M	1.13%	4,579,500 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 500(R) ETF SPDR SERIES TRUST	SPYM	$259.62M	0.22%	4,280,566 NS	FIGI
VANGUARD EQUITY INCOME FUND VANGUARD FENWAY FUNDS	—	$251.47M	0.40%	4,146,327 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERBMY
FIGI_COMPOSITEBBG000DQLV23
FIGI_SHARE_CLASSBBG001S8N8J6
CIK0000014272
ISINUS1101221083
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 1
Model: deepseek
Rationale: Bristol-Myers Squibb is a pharmaceutical company, classified under healthcare with pharmaceuticals as its primary industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.